Exploring Questions Remaining for BTK Inhibitors and B-Cell Malignancies
August 25th 2020Kami J. Maddocks, MD, discusses the use of Bruton’s tyrosine kinase inhibitors in patients with B-cell malignancies and how that may change in the future to provide more treatment options for these patients.
Watch
Newly Diagnosed ALK+ Non–Small Cell Lung Cancer
August 21st 2020Medstar Georgetown University Hospital’s Dr Stephen Liu shares impressions on the way a 57-year-old man with ALK-positive metastatic non–small cell lung cancer was managed, highlighting the rationale for using a second-generation ALK inhibitor as treatment.
Watch